This is interesting from both a medical and business perspective.
The company is Advanced Oncotherapy who look to be acquiring the ADAM spinoff from CERN.
Too early to invest in IMO unless a long term risk investor but great development opportunity, and hopefully another way forward in treating cancer in the future.
More information from AVO and CERN:
http://home.web.cern.ch/about/updates/2013/04/accelerators-medicine
http://www.advancedoncotherapy.com/
Cheers
Orb
The company is Advanced Oncotherapy who look to be acquiring the ADAM spinoff from CERN.
Too early to invest in IMO unless a long term risk investor but great development opportunity, and hopefully another way forward in treating cancer in the future.
from Advanced Oncotherapy PLC site said:In April 2013, AVO announced it's potential acquisition of ADAM-Geneva, a CERN spin-off company based on the CERN campus, home of the LHC and the discovery of the 'God particle.'
AVO’s ADAM-Geneva physics team have created a compact linear accelerator that will be the next generation of targeted cancer treatment. The team‘s aim is to dramatically reduce the cost of delivering enhanced radiotherapy in the clinical setting. Thus, AVO makes radiotherapy more accessible to more patients with lower side effects and better outcomes. Currently, the cost and size of proton beam therapy machines and the necessary edifices to house them explain why there are only 32 centres in the world.
More information from AVO and CERN:
http://home.web.cern.ch/about/updates/2013/04/accelerators-medicine
http://www.advancedoncotherapy.com/
Cheers
Orb
Last edited: